Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?
- 1 May 2021
- journal article
- letter
- Published by Elsevier in Joint Bone Spine
- Vol. 88 (3) , 105150
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Can SARS-CoV-2 trigger reactive arthritis?Joint Bone Spine, 2021
- CoVid-19 related dactyitisJoint Bone Spine, 2020
- The COVID-19 Cytokine Storm; What We Know So FarFrontiers in Immunology, 2020
- Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19Allergy, 2020
- Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndromeJoint Bone Spine, 2020
- [Polymyalgia rheumatica: diagnostic and therapeutic issues of an apparently straightforward disease.]2017
- 2015 Recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiativeAnnals of the Rheumatic Diseases, 2015
- Serum interleukin‐6 receptor in polymyalgia rheumatica: A potential marker of relapse/recurrence riskArthritis Care & Research, 2008
- A disease activity score for polymyalgia rheumaticaAnnals of the Rheumatic Diseases, 2004